febuxostat has been researched along with Anemia, Sickle Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bachman, TN; Baust, JJ; Du, J; Ghosh, S; Hahn, SA; Kelley, EE; Lebensburger, JD; Lewis, SE; McMahon, B; Ofori-Acquah, SF; Oh, JY; Patel, RP; Schmidt, HM; Straub, AC; Vitturi, DA; Wang, Y; Williams, XM; Wood, KC; Yuan, S | 1 |
1 other study(ies) available for febuxostat and Anemia, Sickle Cell
Article | Year |
---|---|
Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.
Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Febuxostat; Hemodynamics; Hemolysis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Artery; Ventricular Function; Xanthine Oxidase | 2021 |